Friday, December 16, 2011

StemCells could gross $20M from offering of stock, warrants

StemCells Inc. could raise up to $20 million by selling 8 million units and an additional 8 million warrants at $1.25 per unit, the Newark company said Friday.
StemCells (NASDAQ: STEM), which is undertaking a Phase I/II study of its neural stem cells in patients with chronic spinal injuries, said Thursday that intended to make the public offering.

No comments:

Post a Comment